Severe Pneumonia and Cytomegalovirus Coinfection in Infants with Human Immunodeficiency Virus Infection

Wonashi R Tsanglao1, Maitreyee Joshi2, Tenukala Aier1

  • 1Consultant, MD Pediatrics, Department of Pediatrics, Christian Institute of Health Sciences and Research, Dimapur, Nagaland, India.

PubMed

Insights

Cytomegalovirus (CMV) causes fatal pneumonia in children with human immunodeficiency virus (HIV). Early detection and care are crucial for infants with HIV and suspected CMV coinfection, especially in India.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Cytomegalovirus (CMV) is a known cause of fatal pneumonia in children with human immunodeficiency virus (HIV).
  • Limited literature exists on pediatric HIV and CMV coinfection in India.
  • Severe pneumonia presents a significant mortality risk in HIV-infected infants.

Purpose of the Study:

  • To describe cases of severe pneumonia in infants with HIV in India.
  • To investigate the role of Cytomegalovirus (CMV) coinfection in these cases.
  • To highlight the importance of antenatal and postnatal care for HIV-positive mothers and their infants.

Main Methods:

  • Retrospective case series of six infants with HIV presenting with severe pneumonia.
  • Detection of CMV coinfection using urine polymerase chain reaction (PCR).
  • Review of antenatal and postnatal care access for all cases.

Main Results:

  • Four out of six infants with HIV had confirmed CMV coinfection.
  • All four infants with CMV coinfection died from severe acute respiratory distress syndrome (ARDS).
  • The two infants without CMV coinfection survived.

Conclusions:

  • A high index of suspicion for CMV is warranted in HIV-infected infants with severe pneumonia.
  • CMV pneumonia diagnosis in this population can be challenging.
  • Antenatal and postnatal care are critical for managing HIV and preventing opportunistic infections like CMV in infants.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
919
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
214
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
224
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
182
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
308
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
230